Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 7, 1997, Pages 870-874

  Laitinen, Pirjo ^a   Happonen, Juha Matti ^a   Sairanen, Heikki ^a   Peltola, Kaija ^a   Rautiainen, Paula ^a   Korpela, Reijo ^a   Leijala, Mauri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Amrinone; Atrioventricular septal defect; Dopamine; Nitroglycerin; Postoperative cardiovascular support

Indexed keywords

AMRINONE; DOPAMINE; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART AFTERLOAD; HEART OUTPUT; HEART PERFORMANCE; HEART SEPTUM DEFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

EID: 0030729695     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90123-3     Document Type: Article

References (18)

1. Bando K, Turrentine MW, Sun K, et al: Surgical management of complete atrioventricular septal defects. A twenty-year experience. J Thorac Cardiovasc Surg 110:1543-1554, 1995
2. Steinberg C, Nötterman DA: Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors. Clin Pharmacokinet 27:345-367, 1994
3. Burrows FA, Klinck JR, Rabinovitch M, Bohn DJ: Pulmonary hypertension in children: Perioperative management. Can Anaesth Soc J 33:606-628, 1986
4. Kozlik-Feldmann R, Kramer H-H, Wicht H, et al: Distribution of myocardial β-adrenoceptor subtypes and coupling to the adenylate cyclase in children with congenital heart disease and implications for treatment. J Clin Pharmacol 33:588-595, 1993
5. Skoyles JR, Sherry KM: Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors. Br J Anaesth 68:293-302, 1992
6. Hess W: Effects of amrinone on the right side of the heart. J Cardiothorac Anesth 3:38-44, 1989 (suppl 2)
7. Butterworth JF, Royster RL, Prielipp RC, et al: Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial. Chest 104:1660-1667, 1993
8. Berner M, Jaccard C, Oberhansli I, et al: Hemodynamic effects of amrinone in children after cardiac surgery. Int Care Med 16:85-88, 1990
9. Lynn AM, Sorensen GK, Williams GD, et al: Hemodynamic effects of amrinone and colloid administration in children following cardiac surgery. J Cardiothorac Anesth 7:560-565, 1993
10. Robinson BW, Gelband H, Mas MS: Selective pulmonary and systemic vasodilator effects of amrinone in children: New therapeutic implications. J Am Coll Cardiol 21:1461-1465, 1993
11. Ruttiman Y, Chioléro R, Revelly J-P, et al: Thermogenic effect of amrinone in healthy men. Crit Care Med 22:1235-1240, 1994
12. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Rev 43:109-142, 1991
13. Gorback MS: Problems associated with the determination of pulmonary vascular resistance. J Clin Monit 6:118-127, 1990
14. Edelson J, LeJemtel TH, Alousi AA, et al: Relationship between amrinone plasma concentration and cardiac index. Clin Pharmacol Ther 29:723-728, 1981
15. Lawless ST, Zaritsky A, Miles M: The acute pharmacokinetics and pharmacodynamics of amrinone in pediatric patients. J Clin Pharmacol 31:800-803, 1991
16. Allen-Webb EM, Ross MP, Pappas JB, et al: Age-related amrinone pharamacokinetics in a pediatric population. Crit Care Med 22:1016-1024, 1994
17. Williams GD, Sorensen GK, Oakes R, et al: Amrinone loading during cardiopulmonary bypass in neonates, infants, and children. J Cardiothorac Anesth 9:278-282, 1995
18. Ross MP, Allen-Webb EM, Pappas JB, McGough EC: Amrinone-associated thrombocytopenia: Pharmacokinetic analysis. Clin Pharmacol Ther 53:661-667, 1993